Lucas Schulz
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 31
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 12
- Drug-Induced Adverse Reactions 6
- Co-authors
- Warren E. Rose (15 shared papers)Barry Fox (13 shared papers)Ravina Kullar (4 shared papers)Michael Postelnick (14 shared papers)David R. Andes (5 shared papers)Graeme N. Forrest (1 shared paper)Trevor Van Schooneveld (1 shared paper)Alexander J. Lepak (15 shared papers)
- Journals
- Open Forum Infectious Diseases (9 papers)American Journal of Health-System Pharmacy (8 papers)Infection Control and Hospital Epidemiology (7 papers)Clinical Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Lucas Schulz
77 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Applied Microbiology and Biotechnology 332
- Clinical Biochemistry 215
- Molecular Medicine 89
- Infectious Diseases 297
- Pharmacology 235
Countries citing papers authored by Lucas Schulz
This map shows the geographic impact of Lucas Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Schulz more than expected).
Fields of papers citing papers by Lucas Schulz
This network shows the impact of papers produced by Lucas Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Schulz. The network helps show where Lucas Schulz may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucas Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 118 | |
| 2 | 2012 | 93 | |
| 3 | 2013 | 76 | |
| 4 | 2019 | 66 | |
| 5 | 2016 | 55 | |
| 6 | 2013 | 44 | |
| 7 | 2020 | 42 | |
| 8 | 2017 | 36 | |
| 9 | 2010 | 33 | |
| 10 | 2003 | 33 | |
| 11 | 2016 | 33 | |
| 12 | 2020 | 31 | |
| 13 | 2012 | 30 | |
| 14 | 2020 | 26 | |
| 15 | 2020 | 22 | |
| 16 | 2019 | 22 | |
| 17 | 2013 | 22 | |
| 18 | 2022 | 21 | |
| 19 | 2022 | 21 | |
| 20 | 2020 | 20 |
About Lucas Schulz
Lucas Schulz is a scholar working on Applied Microbiology and Biotechnology, Pharmacology, Infectious Diseases, Epidemiology and Clinical Biochemistry, having authored 78 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (31 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Identification and Susceptibility Testing (11 papers), Drug-Induced Adverse Reactions (6 papers), Cytomegalovirus and herpesvirus research (5 papers), Antibiotic Resistance in Bacteria (3 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (332 citations), Clinical Biochemistry (215 citations), Molecular Medicine (89 citations), Infectious Diseases (297 citations) and Pharmacology (235 citations). Lucas Schulz has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Warren E. Rose, Barry Fox, Ravina Kullar, Michael Postelnick, David R. Andes, Graeme N. Forrest, Trevor Van Schooneveld, Alexander J. Lepak, Paul R. Hutson and Andrew D. Berti. Their work appears in journals such as Open Forum Infectious Diseases, American Journal of Health-System Pharmacy, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.